Cellares
About Cellares
Cellares is the first Integrated Development and Manufacturing Organization (IDMO) focused on mass-manufacturing living cell therapies with an Industry 4.0 approach. The company designs, develops, and operates integrated technologies to enable scalable, automated cell therapy production, accelerating access to life-saving treatments. Its global footprint includes smart factories in South San Francisco, Bridgewater, and upcoming European and Asian facilities, supporting preclinical through commercial stages. Cellares combines modular hardware (Cell Shuttle, Consumable Cartridge, Cell Q) with flexible software to provide end-to-end automation and high-throughput manufacturing for cell therapies.
Recent News
CAR T Cell Therapy Biomanufactured by Cellares Infused Into First Two Patients
Cellares Inks Long-Term Lease for IDMO Smart Factory at Leiden Bio Science Park
Cellares Raises $257M to Fund Global Expansion as It Eyes 2027 IPO
Cellares and City of Hope Sign Deal to Automate Solid Tumor CAR T Cell Therapy Manufacturing
Cellares Raises $257M in Series D Funding
